rs1447295: Understanding Prostate Cancer Risk Associations
The genetic variant rs1447295 is a single nucleotide polymorphism (SNP) located on chromosome 8q24. It has been identified in various genome-wide association studies as being linked to an increased risk of developing prostate cancer.
What each genotype means
Typical risk profile
This genotype represents the common genetic state at this location. Research in Japanese populations has investigated this variant for potential links to familial prostate cancer, though findings remain specific to certain cohorts and are not considered diagnostic. You should discuss any concerns regarding prostate health or screening with your healthcare provider.
This genotype is common in the Japanese population, though exact frequencies vary by specific ancestral background.
Potential risk association
This genotype has been studied in the context of prostate cancer susceptibility in specific populations. While some research suggests an association with familial prostate cancer, these results are not definitive and do not predict individual health outcomes. Please consult with your physician to determine if routine clinical monitoring is appropriate for your personal health history.
This genotype is observed in a subset of the Japanese population, with frequency data varying across different familial and sporadic study groups.
Potential risk association
This genotype has been investigated for its potential role in prostate cancer risk within specific research cohorts. Current evidence is limited and primarily focused on Japanese populations, meaning it cannot be used to determine your personal risk level. Always discuss your family history and screening needs with a qualified medical professional.
This genotype is less common than the major allele in the Japanese population, with prevalence rates dependent on the specific study population analyzed.
What is rs1447295?
A single nucleotide polymorphism, or SNP, is a variation at a single position in a DNA sequence among individuals. The variant rs1447295 is located on chromosome 8q24, a region of the human genome that has been extensively studied for its role in prostate cancer susceptibility. This specific location is often referred to as an intergenic region, meaning it does not sit within the protein-coding sequence of a known gene, though it is frequently associated with the CASC8 gene in literature. Because it is a non-coding variant, researchers believe it may influence the regulation of nearby genes rather than altering a protein's structure directly. Understanding these non-coding variants is a major focus of modern genomics, as they help explain how subtle changes in our DNA can influence complex disease traits across different populations.
Research and Evidence
The association between rs1447295 and prostate cancer has been observed in multiple large-scale genome-wide association studies (GWAS). These studies compare the DNA of individuals with prostate cancer to those without the disease to identify markers that appear more frequently in the affected group. Evidence for this variant is generally considered moderate, as it is one of many genetic factors that contribute to overall risk. While the statistical link is well-documented in populations of European ancestry, the strength of this association can vary significantly when looking at diverse ethnic groups. It is important to note that having this variant does not mean an individual will develop prostate cancer; rather, it is a statistical marker that contributes to a broader polygenic risk profile. Researchers continue to refine these findings by integrating data from larger, more diverse cohorts to better understand the biological mechanisms at play.
Population Frequency
The frequency of the alleles at the rs1447295 locus varies across different global populations. Genetic databases indicate that the variant is relatively common, but the specific distribution of the A and C alleles differs depending on ancestral background. Because allele frequencies are not uniform, the impact of this variant on population-level risk assessment is highly dependent on the demographic being studied. Researchers use this frequency data to calibrate polygenic risk scores, which are tools designed to estimate an individual's genetic predisposition to a disease. However, because many early GWAS were heavily skewed toward European populations, there is an ongoing effort to increase ancestral diversity in genetic research. This ensures that findings related to variants like rs1447295 are accurate and applicable to a wider range of people, preventing biases in how we interpret genetic risk across different communities.
What This Information Means for You
If you have encountered information about rs1447295, it is essential to view it as a piece of a much larger puzzle. Genetic variants are only one factor in the development of prostate cancer; lifestyle, environment, and family history play significant roles as well. This information is intended for educational purposes and should not be used to diagnose or predict personal health outcomes. You cannot change your genetic code, but understanding your risk factors can help you have more informed conversations with your healthcare provider. If you are concerned about your prostate cancer risk, the best course of action is to discuss your family history and appropriate screening schedules with a physician. They can provide personalized guidance based on your overall health profile, rather than relying on a single genetic marker. Always consult with a medical professional before making decisions about your health or clinical monitoring.
How common is this variant?
The variant rs1447295 is common, with a global minor allele frequency reported around 0.18, though this varies significantly by ancestry.
Frequently asked questions
Does having the A allele mean I will get prostate cancer?
No. Genetic variants like rs1447295 only indicate a statistical association with risk, not a certainty of disease. Many other factors, including age, family history, and lifestyle, are much more influential in determining your actual health outcomes.
Should I get tested for rs1447295?
Routine testing for this specific SNP is not currently a standard part of clinical care. If you are concerned about prostate cancer, you should speak with your doctor about established screening methods, such as PSA testing, which are based on clinical guidelines rather than individual SNP results.
Is this variant only found in certain ethnicities?
No, the variant is found across many populations, but its frequency and the strength of its association with prostate cancer can differ between groups. Most research to date has focused on European populations, so more data is needed to understand its impact in other ancestries.
Can I change my risk if I have this variant?
While you cannot change your DNA, you can manage your overall health through regular check-ups and healthy lifestyle choices. Discussing your personal and family health history with a doctor is the most effective way to manage your risk for prostate cancer.
Sources & further reading
Educational information only, last refreshed 9/21/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1447295?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants
This variant is a clinically relevant marker in Asian populations often analyzed for its impact on drug transport and metabolic fitness.
Located between HLA-DRB1 and HLA-DQA1, this variant is associated with an increased risk of non-Hodgkin's lymphoma in Hepatitis C patients.
This variant is a lead SNP associated with Alzheimer's disease and related dementias, identified through cross-trait analysis with hippocampal volume.
This intronic variant in the NOTCH4 gene is associated with susceptibility to mixed cryoglobulinemia and other lymphoproliferative disorders in patients with Hepatitis C.
This SNP serves as a lead locus for Alzheimer's disease and related dementias, showing significant association with hippocampal volumetric phenotypes.
This variant near the BMP2 gene is associated with variations in retinal nerve fiber layer thickness, a key biomarker for glaucoma risk.